CTRI/2020/02/023631RecruitingPhase 3
A study evaluating the efficacy of Axillary Reverse Mapping in biopsy proven patients undergoing upfront surgery - ARM
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Tata Memorial Centre
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Biopsy confirmed early breast cancer with clinical N0/N1 axilla
Exclusion Criteria
- •1. Matted nodes in the axilla or locally advanced breast cancer
- •2.Prior surgeries in the upper limb, axilla or breast
- •3.Prior treatment for breast cancer including neoadjuvant chemotherapy
- •4.Pregnant woman
- •5. Allergies to Indocyanine dye or blue dye
Investigators
Similar Trials
Completed
Phase 1
Validation for safety and efficacy of axillary reverse mapping using ICG in terms of prevention for lymphedema of upper limb in breast cancerbreast cancerJPRN-UMIN000031880agasaki University15
Active, not recruiting
Not Applicable
A phase II study to investigate the efficacy of RAD001 (Afinitor®, everolimus) in patients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinoma - THYRRAD, CRAD001CNL08TPatients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinoma will be treated in a phase II study to investigate the efficacy of RAD001 (Afinitor®, everolimus).EUCTR2009-016669-27-NLeiden University Medical Center
Completed
Phase 2
A phase II study to investigate the efficacy of RAD001 (Afinitor ®, everolimus) in patients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinomathyroid cancerNL-OMON35047eids Universitair Medisch Centrum42
Completed
Not Applicable
Role of Aparajit Avaleha in treatment of Dry CoughCTRI/2019/12/022302Department of Kaumarbhritya30
Not yet recruiting
Phase 3
Clinical study to evaluate the effectiveness of rectal culture before prostate biopsy to prevent postoperative bacterial prostatitis, multicenter, randomized controlled trial in Japaacute bacterial prostatitisJPRN-UMIN000039478Okayama University5,000
